// App-Quantinova.ai

: A prospective study comparing the repeatability and sensitivity to change of non-invasive endpoints in pulmonary arterial hypertension: the RESPIRE study

Researchers

Presenter

  • David Kiely

Principal Investigators

  • Andy Swift

  • Marcella Cogliano

  • Lindsay Kendall

  • Charlotte Oram

  • Dave Capener

  • Alex Rothman

  • Pankaj Garg

  • Chris Johns

  • Matt Austin

  • Jo Pickworth

  • Peter Hickey

  • Tony Kahn

  • Allan Lawrie

  • Robin Condliffe

  • Fred Wilson

  • Jim Wild

Medical Centers

  • Sheffield Pulmonary Vascular Disease Unit, Sheffield (South Yorkshire, United Kingdom

  • University of Sheffield, Sheffield, United Kingdom

  • GlaxoSmithKline, Stevenage, United Kingdom.

  • Sheffield Hallam University, Sheffield, United Kingdom

  • Sheffield Pulmonary Vascular Disease Unit, Sheffield (South Yorkshire, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved